Catalog No.:AA002KBY

209808-06-0 | 1-Boc-4-(4-Chlorobenzoyl)piperidine

Name: Name:1-Boc-4-(4-Chlorobenzoyl)piperidine
Brand: AABLOCKS
SKU: AA002KBY
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

1mg

3 weeks

$358.00 $250.00

- +

5mg

3 weeks

$398.00 $278.00

- +

10mg

3 weeks

$426.00 $298.00

- +

25mg

3 weeks

$529.00 $370.00

- +

50mg

3 weeks

$743.00 $520.00

- +

100mg

3 weeks

$1,029.00 $720.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA002KBY

Chemical Name:

1-Boc-4-(4-Chlorobenzoyl)piperidine

CAS Number:

209808-06-0

Molecular Formula:

C17H22ClNO3

Molecular Weight:

323.8145

MDL Number:

MFCD04114989

SMILES:

O=C(c1ccc(cc1)Cl)C1CCN(CC1)C(=O)OC(C)(C)C

Properties

BP:

437.443 °C at 760 mmHg

Downstream Synthesis Route

24424-99-5

55695-51-7

209808-06-0

[1]Patent:US2013/324576,2013,A1.Locationinpatent:Paragraph0689;0690;0691

[2]Patent:WO2013/179024,2013,A1.Locationinpatent:Page/Pagecolumn67-68

[3]Patent:WO2014/202999,2014,A1.Locationinpatent:Page/Pagecolumn39;40

[4]JournalofMedicinalChemistry,2008,vol.51,p.2147-2157

[5]Patent:WO2006/46023,2006,A1.Locationinpatent:Page/Pagecolumn137

[6]Patent:WO2006/51290,2006,A2.Locationinpatent:Page/Pagecolumn135-136

[7]Patent:WO2007/125315,2007,A2.Locationinpatent:Page/Pagecolumn134-135

[8]Patent:WO2007/125320,2007,A1.Locationinpatent:Page/Pagecolumn131

[9]JournalofMedicinalChemistry,2000,vol.43,p.3895-3905

77350-52-8

209808-06-0

209808-08-2

[1]Wei;Brown;Takasaki;Plobeck;Delorme;Zhou;Yang;Jones;Gawell;Gagnon;Schmidt;Yue;Walpole;Payza;St-Onge;Labarre;Godbout;Jakob;Butterworth;Kamassah;Morin;Projean;Ducharme;Roberts[JournalofMedicinalChemistry,2000,vol.43,#21,p.3895-3905]

209808-06-0

639468-65-8

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2013/324576,2013,A1Locationinpatent:Paragraph0692;0693;0694

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2013/179024,2013,A1Locationinpatent:Page/Pagecolumn68

[3]CurrentPatentAssignee:MERCK&COINC-US2007/10513,2007,A1Locationinpatent:Page/Pagecolumn15

[4]CurrentPatentAssignee:ROCHEHOLDINGAG;PFIZERINC-WO2009/89462,2009,A1Locationinpatent:Page/Pagecolumn47

[5]Orjales,Aurelio;Mosquera,Ramón;Toledo,Antonio;Pumar,M.Carmen;García,Neftalí;Cortizo,Lourdes;Labeaga,Luis;Innerárity,Ana[JournalofMedicinalChemistry,2003,vol.46,#25,p.5512-5532]

[6]CurrentPatentAssignee:EXELIXISINC-WO2006/71819,2006,A1Locationinpatent:Page/Pagecolumn92

639468-65-8

209808-06-0

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2004/5255,2004,A1Locationinpatent:Page42

160296-40-2

209808-06-0

[1]Patent:US6187792,2001,B1

Literature

Quotation Request

Company Name:

Contact Person:

Email: